Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Visterra Inc.
3109
Visterra Inc.
Technology
Biotechnology
Visterra researches on and develops therapeutic and diagnostic products for thetreatment of infectious diseases.
Suggest edits
Type
B2c
Founded
2007
Raised
$67.7M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
AWSensors
Ovensa Inc.
Vicarius Pharma
AgroSpheres
HARMONY BIOSCIENCE INC.
ParagonGenomics
AnchorDX
Kymera Therapeutics
Metacrine
CC Diagnostics
Alexa global traffic share
Overview
Funding
4
Add info
Acquired by
1
04 Sep 2018
Otsuka Pharmaceutical Company Limited
$430,000,000
Latest funding
Show all
$23,600,000
Venture capital (Series C) - 2017
Flagship Ventures
Polaris Partners
Cycad Group
+8
$30,000,000
Venture capital (Series B) - 2014
Flagship Ventures
Polaris Partners
Cycad Group
+5
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
$430,000,000
PE HUB
Otsuka completes Visterra acquisition for about $430 mln
PE HUB
Otsuka to buy VC-backed Visterra for about $430 mln
Health
$23,600,000
Venture capital (Series C)
PE HUB
CTI Life Sciences invests in Visterra's $46.7 mln Series C
Health
Funding
Xconomy
Visterra, Braeburn Stumble After Solid ’17 Start for Bio IPOs
Health
Stock markets